{{Rsnum
|rsid=16906916
|Chromosome=10
|position=56848985
|Orientation=plus
|GMAF=0.06198
|Assembly=GRCh37.p5
|GenomeBuild=37.3
|dbSNPBuild=137
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}
{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 98.2 | 1.8 | 0.0
| HCB | 72.8 | 24.3 | 2.9
| JPT | 76.1 | 21.2 | 2.7
| YRI | 87.8 | 12.2 | 0.0
| ASW | 93.0 | 7.0 | 0.0
| CHB | 72.8 | 24.3 | 2.9
| CHD | 71.6 | 26.6 | 1.8
| GIH | 96.0 | 4.0 | 0.0
| LWK | 85.5 | 13.6 | 0.9
| MEX | 82.8 | 15.5 | 1.7
| MKK | 91.7 | 7.7 | 0.6
| TSI | 94.1 | 5.9 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22491018
|Trait=None
|Title=Genome-wide association analysis implicates the involvement of eight loci with response to tocilizumab for the treatment of rheumatoid arthritis.
|RiskAllele=
|Pval=8E-7
|OR=14.0000
|ORtxt=None
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}